Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2016, Vol. 10 Issue (4) : 410-419    https://doi.org/10.1007/s11684-016-0489-0
RESEARCH ARTICLE
Inhibition of the nuclear export of p65 and IQCG in leukemogenesis by NUP98-IQCG
Mengmeng Pan1,Qiyao Zhang1,2,Ping Liu1,Jinyan Huang1,Yueying Wang1(),Saijuan Chen1,2()
1. State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine, Shanghai 200025, China
2. Institute of Health Sciences, Shanghai Institutes for Biological Sciences and Graduate School, Chinese Academy of Sciences and SJTU School of Medicine, Shanghai 200025, China
 Download: PDF(437 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

NUP98 fuses with approximately 34 different partner genes via translocation in hematological malignancies. Transgenic or retrovirus-mediated bone marrow transplanted mouse models reveal the leukemogenesis of some NUP98-related fusion genes. We previously reported the fusion protein NUP98-IQ motif containing G (IQCG) in a myeloid/T lymphoid bi-phenoleukemia patient with t(3;11) and confirmed its leukemogenic ability. Herein, we demonstrated the association of NUP98-IQCG with CRM1, and found that NUP98-IQCG expression inhibits the CRM1-mediated nuclear export of p65 and enhances the transcriptional activity of nuclear factor-κB. Moreover, IQCG could be entrapped in the nucleus by NUP98-IQCG, and the fusion protein interacts with calmodulin via the IQ motif in a calcium-independent manner. Therefore, the inhibition of nuclear exports of p65 and IQCG might contribute to the leukemogenesis of NUP98-IQCG.

Keywords NUP98-IQCG      nuclear export      NF-κB      CRM1     
Corresponding Author(s): Yueying Wang,Saijuan Chen   
Just Accepted Date: 07 November 2016   Online First Date: 21 November 2016    Issue Date: 01 December 2016
 Cite this article:   
Mengmeng Pan,Qiyao Zhang,Ping Liu, et al. Inhibition of the nuclear export of p65 and IQCG in leukemogenesis by NUP98-IQCG[J]. Front. Med., 2016, 10(4): 410-419.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-016-0489-0
https://academic.hep.com.cn/fmd/EN/Y2016/V10/I4/410
Fig.1  NUP98-IQCG associates with CRM1. HEK293T cells were transfected with either pEGFP-empty (GFP) or NUP98-IQCG (NI)-expressing vector. The cells were immunostained with anti-CRM1 antibody combined with Alexa Fluor 594-conjugated secondary antibody (red). Transfected Cells were treated with 10 nmol/L LMB for 2 h before fixation in LMB group (+ LMB). The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm.
Fig.2  NUP98-IQCG entraps p65 in nucleus in HEK293T cells. (A) Schematics of the pEGFP vector carrying NUP98-IQCG (NI), NUP98, IQCG, NI without the IQCG portion (NIΔIQCG), or NI without the NUP98 portion (NIΔNUP98). (B) HEK293T cells were transfected with either pEGFP empty vector (GFP), or vectors expressing NUP98-IQCG (NI), NUP98, IQCG, NIΔIQCG, or NIΔNUP98. The cells were immunostained with anti-p65 antibody combined with Alexa Fluor 594-conjugated secondary antibody (red). The untransfected cells were treated with 10 nmol/L LMB for 2 h before fixation in LMB group. The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm. (C) Histogram of the relative proportions of cells with varying subcellular localization of p65 in transfected HEK293T cells. Cells were classified into three categories according to the distribution of p65: all concentrated in cytoplasm (C), localized primarily in the cytoplasm (cytoplasm>nucleus, C>N), or equally present in the cytoplasm and in the nucleus (cytoplasm ≈ nucleus, C ≈ N). Error bars represent the mean±SD of three independent experiments. (D) COS-7 cells were transfected with either pEGFP-empty (GFP) or NUP98-IQCG (NI)-expressing vector. The cells were immunostained with anti-p65 antibody combined with Alexa Fluor 594-conjugated secondary antibody (red). The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm. (E) GFP+ bone marrow cells isolated from control and NUP98-IQCG (NI) mice were immunostained with anti-p65 primary antibody and Alexa Fluor 594-conjugated secondary antibody (red). The nuclei were visualized by Hoechst staining (blue). Bar, 20 mm.
Fig.3  NUP98-IQCG has no effect on the subcellular localizations of p50 and IkBa. HEK293T (A and B) and COS-7 cells (C and D) were transfected with either pEGFP-empty (GFP) or NUP98-IQCG (NI)-expressing vector. The cells were immunostained with anti-p50 (A and C) or anti-IkBa (B and D) antibodies combined with Alexa Fluor 594-conjugated secondary antibody (red). The untransfected cells were treated with 10 nmol/L LMB for 2 h before fixation in the LMB group. The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm.
Fig.4  NUP98-IQCG-induced p65 nuclear retention and NF-kB activation are associated with the inhibition of CRM1-mediated nuclear export. (A) HEK293T cells were transfected with pEGFP-tagged CRM1 (CRM1) with (lower panel) or without (upper panel) the LMB treatment. The cells were immunostained with anti-p65 antibody combined with Alexa Fluor 594-conjugated secondary antibody (red). The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm. (B) HEK293T cells were transiently transfected with mCherry-NI (red) combined with pEGFP-empty (GFP) or CRM1-expressing vector (green) with or without LMB treatment. The cells were immunostained with anti-p65 antibody combined with Alexa Fluor 647-conjugated secondary antibody (purple). The nuclei were visualized by Hoechst staining (blue). Bar, 10 mm. (C) The protein levels of p65, p50, and IkBa in HEK293T cells transfected with pEGFP-empty (GFP) or NUP98-IQCG (NI)-expressing vector. b-actin and a-tubulin serve as loading controls. (D) Activation of NF-kB-firefly luciferase by NUP98-IQCG (NI). NUP98-HOXA9 (NH9) was used as a positive control. All transfection experiments were performed in triplicate and repeated thrice. *P<0.05; **P<0.01.
Fig.5  NUP98-IQCG causes nuclear retention of IQCG. (A) Schematics of the mCherry vector carrying NUP98-IQCG (NI), and the pEGFP vector carrying NUP98, IQCG, or NI without the IQCG portion (NIΔIQCG). (B) HEK293T cells were transiently transfected with mCherry-NI (red, left panel) combined with pEGFP vectors expressing NUP98, IQCG, or NIΔIQCG (green). Hoechst staining was used to detect the nucleus (blue). Bar, 10 mm. (C) HEK293T cells were transiently transfected with pEGFP-IQCG (green, left panel) combined with either mCherry-empty (mCherry) or NUP98-IQCG-expressing (mCherry-NI) vector (red). Hoechst staining was used to detect the nucleus (blue). Cells transfected with pEGFP-IQCG (bottom panels) combined with empty mCherry were treated with 10 nmol/L LMB for 2 h before fixation. Bar, 10 mm. (D) Histogram of the relative proportions of cells with varying subcellular localization of IQCG. Cells were classified into three categories according to IQCG distribution: all concentrated in cytoplasm (C), localized primarily in the cytoplasm (cytoplasm>nucleus, C>N), or equally present in the cytoplasm and in the nucleus (cytoplasm ≈ nucleus, C ≈ N). Error bars represent the mean±SD of three independent experiments.
Fig.6  NUP98-IQCG interacts with CaM and the calcium signaling pathway is dysregulated in NUP98-IQCG mice. (A) Ability of NUP98-IQCG (NI) and NUP98-IQCGΔIQ (NIΔIQ) to interact with CaM under varying calcium concentrations, as determined by Co-IP experiments. Anti-Flag M2 magnetic beads were used for immunoprecipitation (IP), and antibodies against CaM or Flag were used for Western blot. (B) GO analysis of downregulated genes via DAVID (FC>2; FDR<0.05). (C) Enrichment plots for gene sets of the calcium signaling pathway identified by GSEA. NES: normalized enrichment score. P: nominal P value. (D) Quantitative RT-PCR of the four genes crucial to the calcium signaling pathway in GFP+ c-Kit+ BM samples of the control (Con) and NUP98-IQCG (NI) mice. Error bars represent mean±SD (n = 3 per group). *P<0.05, **P<0.01, ***P<0.001.
1 Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD Jr. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 1996; 12(2): 154–158
https://doi.org/10.1038/ng0296-154 pmid: 8563753
2 Borrow J, Shearman AM, Stanton VP Jr, Becher R, Collins T, Williams AJ, Dubé I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 1996; 12(2): 159–167
https://doi.org/10.1038/ng0296-159 pmid: 8563754
3 Franks TM, Hetzer MW. The role of Nup98 in transcription regulation in healthy and diseased cells. Trends Cell Biol 2013; 23(3): 112–117
https://doi.org/10.1016/j.tcb.2012.10.013 pmid: 23246429
4 Takeda A, Sarma NJ, Abdul-Nabi AM, Yaseen NR. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J Biol Chem 2010; 285(21): 16248–16257
https://doi.org/10.1074/jbc.M109.048785 pmid: 20233715
5 Fontoura BM, Blobel G, Yaseen NR. The nucleoporin Nup98 is a site for GDP/GTP exchange on ran and termination of karyopherin beta 2-mediated nuclear import. J Biol Chem 2000; 275(40): 31289–31296
https://doi.org/10.1074/jbc.M004651200 pmid: 10875935
6 Radu A, Moore MS, Blobel G. The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex. Cell 1995; 81(2): 215–222
https://doi.org/10.1016/0092-8674(95)90331-3 pmid: 7736573
7 Blevins MB, Smith AM, Phillips EM, Powers MA. Complex formation among the RNA export proteins Nup98, Rae1/Gle2, and TAP. J Biol Chem 2003; 278(23): 20979–20988
https://doi.org/10.1074/jbc.M302061200 pmid: 12637516
8 Taketani T, Taki T, Shibuya N, Kikuchi A, Hanada R, Hayashi Y. Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13). Cancer Res 2002; 62(16): 4571–4574
pmid: 12183408
9 Raza-Egilmez SZ, Jani-Sait SN, Grossi M, Higgins MJ, Shows TB, Aplan PD. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 1998; 58(19): 4269–4273
pmid: 9766650
10 Jankovic D, Gorello P, Liu T, Ehret S, La Starza R, Desjobert C, Baty F, Brutsche M, Jayaraman PS, Santoro A, Mecucci C, Schwaller J. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia. Blood 2008; 111(12): 5672–5682
https://doi.org/10.1182/blood-2007-09-108175 pmid: 18388181
11 Nakamura T, Yamazaki Y, Hatano Y, Miura I. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15). Blood 1999; 94(2): 741–747
pmid: 10397741
12 Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011; 118(24): 6247–6257
https://doi.org/10.1182/blood-2011-07-328880 pmid: 21948299
13 Yassin ER, Abdul-Nabi AM, Takeda A, Yaseen NR. Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Leukemia 2010; 24(5): 1001–1011
https://doi.org/10.1038/leu.2010.42 pmid: 20339440
14 Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007; 9(7): 804–812
https://doi.org/10.1038/ncb1608 pmid: 17589499
15 Pan Q, Zhu YJ, Gu BW, Cai X, Bai XT, Yun HY, Zhu J, Chen B, Weng L, Chen Z, Xue YQ, Chen SJ. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation. Oncogene 2008; 27(24): 3414–3423
https://doi.org/10.1038/sj.onc.1210999 pmid: 18084320
16 Hussey DJ, Dobrovic A. Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood 2002; 99(3): 1097–1098
https://doi.org/10.1182/blood.V99.3.1097 pmid: 11822362
17 Pan MM, Zhang QY, Wang YY, Liu P, Ren RB, Huang JY, Chen LT, Xi XD, Chen Z, Chen SJ. Human NUP98-IQCG fusion protein induces acute myelomonocytic leukemia in mice by dysregulating the Hox/Pbx3 pathway. Leukemia 2016; 30(7): 1590–1593 doi:10.1038/leu.2015.347
pmid: 26675333
18 Baldwin AS Jr. The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14(1): 649–681
https://doi.org/10.1146/annurev.immunol.14.1.649 pmid: 8717528
19 Wang Y, Mo X, Piper MG, Wang H, Parinandi NL, Guttridge D, Marsh CB. M-CSF induces monocyte survival by activating NF-kB p65 phosphorylation at Ser276 via protein kinase C. PLoS ONE 2011; 6(12): e28081
https://doi.org/10.1371/journal.pone.0028081 pmid: 22216091
20 Oka M, Asally M, Yasuda Y, Ogawa Y, Tachibana T, Yoneda Y. The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export. Mol Biol Cell 2010; 21(11): 1885–1896
https://doi.org/10.1091/mbc.E09-12-1041 pmid: 20375145
21 Li RK, Tan JL, Chen LT, Feng JS, Liang WX, Guo XJ, Liu P, Chen Z, Sha JH, Wang YF, Chen SJ. Iqcg is essential for sperm flagellum formation in mice. PLoS ONE 2014; 9(5): e98053
https://doi.org/10.1371/journal.pone.0098053 pmid: 24849454
22 Chen LT, Liang WX, Chen S, Li RK, Tan JL, Xu PF, Luo LF, Wang L, Yu SH, Meng G, Li KK, Liu TX, Chen Z, Chen SJ. Functional and molecular features of the calmodulin-interacting protein IQCG required for haematopoiesis in zebrafish. Nat Commun 2014; 5(5): 3811
pmid: 24787902
23 Kitsos CM, Sankar U, Illario M, Colomer-Font JM, Duncan AW, Ribar TJ, Reya T, Means AR. Calmodulin-dependent protein kinase IV regulates hematopoietic stem cell maintenance. J Biol Chem 2005; 280(39): 33101–33108
https://doi.org/10.1074/jbc.M505208200 pmid: 16020540
24 Monaco S, Rusciano MR, Maione AS, Soprano M, Gomathinayagam R, Todd LR, Campiglia P, Salzano S, Pastore L, Leggiero E, Wilkerson DC, Rocco M, Selleri C, Iaccarino G, Sankar U, Illario M. A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells. Cell Signal 2015; 27(2): 204–214
https://doi.org/10.1016/j.cellsig.2014.11.007 pmid: 25446257
25 Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013; 14(4): R36
https://doi.org/10.1186/gb-2013-14-4-r36 pmid: 23618408
26 Anders S, Pyl PT, Huber W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 2015; 31(2): 166–169
https://doi.org/10.1093/bioinformatics/btu638 pmid: 25260700
27 Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010; 26(1): 139–140
https://doi.org/10.1093/bioinformatics/btp616 pmid: 19910308
28 Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4(1): 44–57
https://doi.org/10.1038/nprot.2008.211 pmid: 19131956
29 Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102(43): 15545–15550
https://doi.org/10.1073/pnas.0506580102 pmid: 16199517
30 Huang TT, Kudo N, Yoshida M, Miyamoto S. A nuclear export signal in the N-terminal regulatory domain of IkBα controls cytoplasmic localization of inactive NF-kB/IkBα complexes. Proc Natl Acad Sci USA 2000; 97(3): 1014–1019
https://doi.org/10.1073/pnas.97.3.1014 pmid: 10655476
31 Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, Bianchini A, Colombo E, Schiavoni I, Badaracco G, Hu X, Lazar MA, Landsberger N, Nervi C, Pelicci PG. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell 2000; 5(5): 811–820
https://doi.org/10.1016/S1097-2765(00)80321-4 pmid: 10882117
32 Tran QK, Black DJ, Persechini A. Intracellular coupling via limiting calmodulin. J Biol Chem 2003; 278(27): 24247–24250
https://doi.org/10.1074/jbc.C300165200 pmid: 12738782
33 Colomer J, Means AR. Physiological roles of the Ca2+/CaM-dependent protein kinase cascade in health and disease. Subcell Biochem 2007; 45: 169–214
https://doi.org/10.1007/978-1-4020-6191-2_7 pmid: 18193638
34 Stewart TA, Yapa KT, Monteith GR. Altered calcium signaling in cancer cells. Biochim Biophys Acta 2015; 1848(10 Pt B): 2502–2511
https://doi.org/10.1016/j.bbamem.2014.08.016 pmid: 25150047
[1] FMD-16255-OF-CSJ_suppl_1 Download
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed